A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance
- PMID: 15351728
- DOI: 10.1016/j.bbrc.2004.08.083
A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance
Abstract
Adiponectin is an anti-diabetic and anti-atherogenic hormone that is exclusively secreted from fat cells. Serum adiponectin levels are reduced in obese patients and obese model mice, despite increased adipose tissue mass. Elucidation of the mechanism(s) by which plasma adiponectin levels are decreased in obese and diabetic patients would provide insight into the cause of obesity-induced diabetes and the development of therapeutic advances. In the present study, the regulation of adiponectin secretion was investigated using 3T3-L1 adipocytes and a diabetic-/obese-mouse model. A novel insulin sensitizer, IkappaB kinase beta (IKKbeta) inhibitor, ameliorated insulin resistance and up-regulated plasma levels of adiponectin without producing a significant change in body weight in KKAy mice that were fed a high-fat diet. The IKKbeta inhibitor cancelled the TNFalpha-mediated down-regulation of adiponectin secretion and simultaneously up-regulated the phosphorylation of Akt in 3T3-L1 adipocytes. Using dominant-negative mutants of Akt or PKClambda (downstream effectors of phosphoinositide 3-kinase), insulin-stimulated Akt activity was found to be important in the regulation of adiponectin secretion by insulin in 3T3-L1 adipocytes. These observations suggest that "insulin-stimulated Akt activity in adipocytes" may play an important role in the regulation of adiponectin secretion.
Copyright 2004 Elsevier Inc.
Similar articles
-
Ginsenoside Rb2 promotes glucose metabolism and attenuates fat accumulation via AKT-dependent mechanisms.Biomed Pharmacother. 2018 Apr;100:93-100. doi: 10.1016/j.biopha.2018.01.111. Epub 2018 Feb 6. Biomed Pharmacother. 2018. PMID: 29425748
-
Insulin up-regulates heme oxygenase-1 expression in 3T3-L1 adipocytes via PI3-kinase- and PKC-dependent pathways and heme oxygenase-1-associated microRNA downregulation.Endocrinology. 2011 Feb;152(2):384-93. doi: 10.1210/en.2010-0493. Epub 2010 Dec 8. Endocrinology. 2011. PMID: 21147878
-
Activation of the mammalian _target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.Endocrinology. 2005 Mar;146(3):1328-37. doi: 10.1210/en.2004-0777. Epub 2004 Dec 2. Endocrinology. 2005. PMID: 15576463
-
[The mechanisms by which PPARgamma and adiponectin regulate glucose and lipid metabolism].Nihon Yakurigaku Zasshi. 2003 Oct;122(4):294-300. doi: 10.1254/fpj.122.294. Nihon Yakurigaku Zasshi. 2003. PMID: 14501164 Review. Japanese.
-
Nuclear receptors as _targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated receptor gamma, CREB-binding protein, and adiponectin.J Pharmacol Sci. 2005 Feb;97(2):164-70. doi: 10.1254/jphs.fmj04008x2. Epub 2005 Feb 11. J Pharmacol Sci. 2005. PMID: 15725703 Review.
Cited by
-
γ-Tocotrienol attenuates TNF-α-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes.Mol Med Rep. 2012 Apr;5(4):905-9. doi: 10.3892/mmr.2012.770. Epub 2012 Jan 30. Mol Med Rep. 2012. PMID: 22293775 Free PMC article.
-
NF-κB activation in retinal microglia is involved in the inflammatory and neovascularization signaling in laser-induced choroidal neovascularization in mice.Exp Cell Res. 2021 Jun 1;403(1):112581. doi: 10.1016/j.yexcr.2021.112581. Epub 2021 Mar 31. Exp Cell Res. 2021. PMID: 33811906 Free PMC article.
-
Adiponectin in inflammatory and immune-mediated diseases.Cytokine. 2013 Oct;64(1):1-10. doi: 10.1016/j.cyto.2013.06.317. Epub 2013 Jul 11. Cytokine. 2013. PMID: 23850004 Free PMC article. Review.
-
Inhibitory kappa B Kinases as _targets for pharmacological regulation.Br J Pharmacol. 2012 Feb;165(4):802-19. doi: 10.1111/j.1476-5381.2011.01608.x. Br J Pharmacol. 2012. PMID: 21797846 Free PMC article. Review.
-
4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascade.Medchemcomm. 2017 Aug 25;8(9):1850-1855. doi: 10.1039/c7md00278e. eCollection 2017 Sep 1. Medchemcomm. 2017. PMID: 30108896 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases